Cannabis-based drug to be made available to NSW children

A small number of children with drug-resistant epilepsy will soon be able to access a new cannabis-based drug in New South Wales which is showing promise in relieving the symptoms.

The pharmaceutical drug, Epidolex, is still in a trial phase and has not yet received full approval from authorities, but the Government has now set the date of March for a compassionate access scheme to begin.

Last year, the NSW Government approached the company that makes the drug, the UK's GW Pharmaceuticals, to see if trials could be arranged in NSW.

Pru Goward, the Minister for Medical Research, said the scheme was great news for families who had children with the condition.

"These families are desperate," Ms Goward told the ABC.

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.